alexa Synthesis Of Doxorubicin-containing Ionic Liquid And Study Of Its Biological Activity
ISSN: 2161-0444

Medicinal Chemistry
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

5th International Conference on Medicinal Chemistry & Computer Aided Drug Designing and Drug Delivery
December 05-07, 2016 Phoenix, USA

Ksenia S Egorova, Fedor A Kucherov, Alexandra V Posvyatenko and Valentine P Ananikov
Russian Academy of Sciences, Russia
Posters & Accepted Abstracts: Med chem
DOI: 10.4172/2161-0444.C1.028
Abstract
Ionic liquids (ILs), or molten salts, possess unique physicochemical and biological properties. The major advantage of ILs is their high tunability: practically any desirable features can be combined within one IL molecule. According to a novel API-IL (active pharmaceutical ingredient – ionic liquid) concept, traditional drugs can benefit from being used in the ionic liquid form. API-ILs is suggested to solve such major drawbacks of many traditional medicines as low solubility and polymorphism. In this work, we used this concept to synthesize API-IL, which contained doxorubicin as a biologically active moiety. Doxorubicin is a DNA intercalating agent commonly applied for treatment of various types of cancers. We introduced the doxorubicin moiety into an imidazolium IL via an amide bond to obtain the resulting API-IL (1-(doxorubicin- 10-carboxydecyl)-3-methylimidazolium bromide). We studied cytotoxicity of the obtained DOX-IL towards Colo 320HSR cells (colon adenocarcinoma) in comparison with cytotoxicity of the pure doxorubicin chloride and 1-(10-carboxydecyl)- 3-methylimidazolium bromide. According to preliminary results, doxorubicin and DOX-IL demonstrated comparable cytotoxicity towards Colo 320HSR cells (24-h IC50 ∼6-9 μM), whereas the IL without the doxorubicin moiety was significantly less cytotoxic (24-h IC50 >3000 μM). Thus, introduction of doxorubicin into an ionic liquid did not disturb the biological activity of the drug. The results evidence promising potential of the API-IL strategy for pharmaceutical research.
Biography

Ksenia S Egorova graduated from Lomonosov Moscow State University with a Master of Science in Biochemistry in 2006. In 2010, she completed her PhD in Molecular Biology at the Institute of Molecular Genetics RAS (Moscow, Russia). Since 2012, she has been a researcher at N D Zelinsky Institute of Organic Chemistry. She is an author of 19 papers and three book chapters. Her interests include biological activity, natural products, cancer proteomics, ionic liquids and carbohydrate research.

Email: [email protected]

image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords